CAS NO: | 127869-51-6 |
包装 | 价格(元) |
500 μg | 电议 |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
生物活性 | C-Type Natriuretic Peptide (CNP) (1-22), human, a 1-22 fragment of CNP, is anatriuretic peptide receptor B(NPR-B) agonist. C-Type Natriuretic Peptide (CNP) (1-22), human inhibits cAMP synthesis stimulated by the physiological agonists histamine and 5-HT or directly by Forskolin. CNP is a potent, endothelial-derived relaxant and growthinhibitory factor[1][2][3]. | ||||||||||||||||||||||||||
IC50& Target | NPR-B[1] | ||||||||||||||||||||||||||
体外研究 (In Vitro) | C-Type Natriuretic Peptide (CNP) (1-22), human (TFA) (0.01, 0.1, 1, 10, 100, 1000 nM) increases cGMP production in CHO cells expressing human NPR-B in a concentration-dependent manner[1]. | ||||||||||||||||||||||||||
体内研究 (In Vivo) | PK parameters of CNP immunoreactivity after a single intravenous administration of C-Type Natriuretic Peptide (CNP) (1-22), human[1]:
i.c.v. administration of C-Type Natriuretic Peptide (CNP) (1-22) in a dose of 2 nM induces an increase in the severity of picrotoxin-kindled convulsions 24 and 48 hrs after application of the peptide[3]. | ||||||||||||||||||||||||||
分子量 | 2197.60 | ||||||||||||||||||||||||||
性状 | Solid | ||||||||||||||||||||||||||
Formula | C93H157N27O28S3 | ||||||||||||||||||||||||||
CAS 号 | 127869-51-6 | ||||||||||||||||||||||||||
Sequence | Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys (Disulfide bridge: Cys6-Cys22) | ||||||||||||||||||||||||||
Sequence Shortening | GLSKGCFGLKLDRIGSMSGLGC (Disulfide bridge: Cys6-Cys22) | ||||||||||||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||||||||||||
储存方式 | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||||||||||||
溶解性数据 | In Vitro: H2O : 10 mg/mL(4.55 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |